Order Article Reprints

Gorombei P, Guidez F, Ganesan S, Chiquet M, Pellagatti A, Goursaud L, Tekin N, Beurlet S, Patel S, Guerenne L, et al. BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome. International Journal of Molecular Sciences. 2021; 22(19):10658. https://doi.org/10.3390/ijms221910658

Gorombei, Petra, Fabien Guidez, Saravanan Ganesan, Mathieu Chiquet, Andrea Pellagatti, Laure Goursaud, Nilgun Tekin, Stephanie Beurlet, Satyananda Patel, Laura Guerenne, and et al. 2021. "BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome" International Journal of Molecular Sciences 22, no. 19: 10658. https://doi.org/10.3390/ijms221910658

Gorombei, P., Guidez, F., Ganesan, S., Chiquet, M., Pellagatti, A., Goursaud, L., Tekin, N., Beurlet, S., Patel, S., Guerenne, L., Le Pogam, C., Setterblad, N., de la Grange, P., LeBoeuf, C., Janin, A., Noguera, M.-E., Sarda-Mantel, L., Merlet, P., Boultwood, J., ... Padua, R. A. (2021). BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome. International Journal of Molecular Sciences, 22(19), 10658. https://doi.org/10.3390/ijms221910658